MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study

Clinical and Translational Radiation Oncology - Tập 38 - Trang 175-182 - 2023
Yirong Xiang1, Shuai Li1, Hongzhi Wang1, Maxiaowei Song1, Ke Hu2, Fengwei Wang3, Zhi Wang4, Zhiyong Niu4, Jin Liu4, Yong Cai1, Yongheng Li1, Xianggao Zhu1, Jianhao Geng1, Yangzi Zhang1, Huajing Teng1, Weihu Wang1
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, China
2Department of Radiation Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, China
3Department of Oncology, Tianjin Union Medical Center, China
4Blot Info & Tech (Beijing) Co. Ltd, China

Tài liệu tham khảo

Kapiteijn, 2001, Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer, N Engl J Med, 345, 638, 10.1056/NEJMoa010580

Bryant, 2012, Anterior resection syndrome, Lancet Oncol, 13, e403, 10.1016/S1470-2045(12)70236-X

Thaysen, 2014, Health-related quality of life after surgery for advanced and recurrent rectal cancer: a nationwide prospective study, Colorectal Dis, 16, O223, 10.1111/codi.12551

Sajid, 2014, Systematic review and meta-analysis of published trials comparing the effectiveness of transanal endoscopic microsurgery and radical resection in the management of early rectal cancer, Colorectal Dis, 16, 2, 10.1111/codi.12474

Creavin, 2017, Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer, Br J Cancer, 116, 169, 10.1038/bjc.2016.417

Stijns, 2019, Long-term oncological and functional outcomes of chemoradiotherapy followed by organ-sparing transanal endoscopic microsurgery for distal rectal cancer: the CARTS study, JAMA Surg, 154, 47, 10.1001/jamasurg.2018.3752

Ahmad, 2021, A meta-analysis of transanal endoscopic microsurgery versus total mesorectal excision in the treatment of rectal cancer, Surg J (N Y), 7, e241, 10.1055/s-0041-1735587

Garcia-Aguilar, 2015, Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial, Lancet Oncol, 16, 957, 10.1016/S1470-2045(15)00004-2

Fokas, 2019, Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12, J Clin Oncol, 37, 3212, 10.1200/JCO.19.00308

Kim, 2018, A Randomized phase 2 trial of consolidation chemotherapy after preoperative chemoradiation therapy versus chemoradiation therapy alone for locally advanced rectal cancer: KCSG CO 14–03, Int J Radiat Oncol Biol Phys, 101, 889, 10.1016/j.ijrobp.2018.04.013

Patel, 2017, MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial, Ann Oncol, 28, 344, 10.1093/annonc/mdw616

Liu, 2020, Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer, Nat Commun, 11, 4308, 10.1038/s41467-020-18162-9

Bulens, 2020, Predicting the tumor response to chemoradiotherapy for rectal cancer: model development and external validation using MRI radiomics, Radiother Oncol, 142, 246, 10.1016/j.radonc.2019.07.033

Delli Pizzi, 2021, MRI-based clinical-radiomics model predicts tumor response before treatment in locally advanced rectal cancer, Sci Rep, 11, 5379, 10.1038/s41598-021-84816-3

Lee, 2018, Partial least squares-discriminant analysis (PLS-DA) for classification of high-dimensional (HD) data: a review of contemporary practice strategies and knowledge gaps, Analyst, 143, 3526, 10.1039/C8AN00599K

Song, 2022, MRI radiomics independent of clinical baseline characteristics and neoadjuvant treatment modalities predicts response to neoadjuvant therapy in rectal cancer, Br J Cancer, 10.1038/s41416-022-01786-7

Wang, 2020, MRI-based radiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma, Br J Cancer, 122, 978, 10.1038/s41416-019-0706-0

Baxter, 2007, Organ preservation for rectal cancer, J Clin Oncol, 25, 1014, 10.1200/JCO.2006.09.7840

Habr-Gama, 2004, Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results, Ann Surg, 240, 10.1097/01.sla.0000141194.27992.32

Moon, 2012, Can the new American Joint Committee on Cancer staging system predict survival in rectal cancer patients treated with curative surgery following preoperative chemoradiotherapy?, Cancer, 118, 4961, 10.1002/cncr.27507

Van den Eynde, 2019, TAMIS is a valuable alternative to TEM for resection of intraluminal rectal tumors, Tech Coloproctol, 23, 161, 10.1007/s10151-019-01954-7

Chaouch, 2021, Early salvage total mesorectal excision (sTME) after organ preservation failure in rectal cancer does not worsen postoperative outcomes compared to primary TME: systematic review and meta-analysis, Int J Colorectal Dis, 36, 2375, 10.1007/s00384-021-03989-5

Rullier, 2017, Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial, Lancet, 390, 469, 10.1016/S0140-6736(17)31056-5

Fernandez, 2020, Salvage surgery with organ preservation for patients with local regrowth after watch and wait: is it still possible?, Dis Colon Rectum, 63, 1053, 10.1097/DCR.0000000000001707

Zhou, 2020, Radiomics-based preoperative prediction of lymph node status following neoadjuvant therapy in locally advanced rectal cancer, Front Oncol, 10, 604, 10.3389/fonc.2020.00604

Kim, 2018, Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: focus on MR imaging findings, PLoS One, 13, e0195815, 10.1371/journal.pone.0195815

Zhu, 2019, Prediction of pathological nodal stage of locally advanced rectal cancer by collective features of multiple lymph nodes in magnetic resonance images before and after neoadjuvant chemoradiotherapy, Chin J Cancer Res, 31, 984, 10.21147/j.issn.1000-9604.2019.06.14

Pomerri, 2017, Prediction of N0 irradiated rectal cancer comparing MRI before and after preoperative chemoradiotherapy, Dis Colon Rectum, 60, 1184, 10.1097/DCR.0000000000000894

Duchalais, 2018, Prognostic value of pathological node status after neoadjuvant radiotherapy for rectal cancer, Br J Surg, 105, 1501, 10.1002/bjs.10867

Kim, 2006, Is T classification still correlated with lymph node status after preoperative chemoradiotherapy for rectal cancer?, Cancer, 106, 1694, 10.1002/cncr.21794

Dumont, 2018, Model predicting the ypN0 status after good response to chemoradiotherapy in rectal cancer, Am J Surg, 216, 438, 10.1016/j.amjsurg.2018.03.025

Wang, 2020, Evaluation of rectal cancer circumferential resection margin using faster region-based convolutional neural network in high-resolution magnetic resonance images, Dis Colon Rectum, 63, 143, 10.1097/DCR.0000000000001519

Liu, 2019, MRI radiomics analysis for predicting preoperative synchronous distant metastasis in patients with rectal cancer, Eur Radiol, 29, 4418, 10.1007/s00330-018-5802-7

Nie, 2016, Rectal cancer: assessment of neoadjuvant chemoradiation outcome based on radiomics of multiparametric MRI, Clin Cancer Res, 22, 5256, 10.1158/1078-0432.CCR-15-2997

Liu, 2017, Radiomics analysis for evaluation of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer, Clin Cancer Res, 23, 7253, 10.1158/1078-0432.CCR-17-1038

Zhang, 2020, Predicting rectal cancer response to neoadjuvant chemoradiotherapy using deep learning of diffusion kurtosis MRI, Radiology, 296, 56, 10.1148/radiol.2020190936

Shayesteh, 2021, Treatment response prediction using MRI-based pre-, post-, and delta-radiomic features and machine learning algorithms in colorectal cancer, Med Phys, 48, 3691, 10.1002/mp.14896

Chiloiro, 2020, Delta radiomics can predict distant metastasis in locally advanced rectal cancer: the challenge to personalize the cure, Front Oncol, 10, 10.3389/fonc.2020.595012

Boldrini, 2019, Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach, Radiol Med, 124, 145, 10.1007/s11547-018-0951-y

Nardone, 2022, Ability of delta radiomics to predict a complete pathological response in patients with loco-regional rectal cancer addressed to neoadjuvant chemo-radiation and surgery, Cancers (Basel), 14, 10.3390/cancers14123004

Hong, 2021, Can normalized carcinoembryonic antigen following neoadjuvant chemoradiation predict tumour recurrence after curative resection for locally advanced rectal cancer?, Colorectal Dis, 23, 1346, 10.1111/codi.15583

Pang, 2021, Associations between clinical characteristics and tumor response to neoadjuvant chemoradiotherapy in rectal cancer, Cancer Med, 10, 4832, 10.1002/cam4.4051

Patel, 2016, Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer, J Surg Oncol, 114, 637, 10.1002/jso.24358

Moore, 2017, Prospective randomized trial of neoadjuvant chemotherapy during the 'wait period' following preoperative chemoradiotherapy for rectal cancer: results of the WAIT trial, Colorectal Dis, 19, 973, 10.1111/codi.13724

Sun, 2018, Radiomic features of pretreatment MRI could identify T stage in patients with rectal cancer: Preliminary findings, J Magn Reson Imaging, 10.1002/jmri.25969

Guo, 2021, Preoperative prediction of perineural invasion with multi-modality radiomics in rectal cancer, Sci Rep, 11, 9429, 10.1038/s41598-021-88831-2

Meng, 2018, MRI texture analysis in predicting treatment response to neoadjuvant chemoradiotherapy in rectal cancer, Oncotarget, 9, 11999, 10.18632/oncotarget.23813

Aker, 2019, Magnetic resonance texture analysis in identifying complete pathological response to neoadjuvant treatment in locally advanced rectal cancer, Dis Colon Rectum, 62, 163, 10.1097/DCR.0000000000001224

De Cecco, 2015, Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance, Invest Radiol, 50, 239, 10.1097/RLI.0000000000000116